Deals
Sleep Apnea Device Maker ProSomnus to Merge with Lakeshore SPAC
- ProSomnus valued at 4.3 times its expected 2023 revenue
- Transaction comes as banks, investors step back from SPACs
This article is for subscribers only.
The SPAC faucet hasn’t completely shut.
ProSomnus Holdings Inc., a maker of devices that treat sleep apnea, has agreed to go public through a merger with a blank-check company, even amid a broader retreat from the asset class.